The Pennant Group enters the post-earnings session with a clean beat on both the top and bottom line — and a short base that has been quietly shrinking for weeks.
Q1 2026 results, released on May 6, showed adjusted EPS of $0.32 against a $0.31 estimate. Revenue came in at $285.4 million, ahead of the $280.7 million consensus. That follows Q4 2025, when the company reported full-year sales of $947.7 million — a 36% jump from $695.2 million the prior year, largely driven by acquisitions. The company also announced this week that it acquired three senior living communities in Arizona and Wisconsin, extending its M&A-led growth strategy. The setup heading into the print was a stock up 6% over the past month, trading at $31.46, and the beat lands against that already constructive backdrop.
Short interest reinforces the cautiously positive mood rather than contradicting it. Bears have been retreating: shorts fell roughly 28% over the past 30 days, from above one million shares in early April to around 773,500 shares now — 2.2% of the free float. That's a meaningful reduction. The share count spiked briefly above one million around April 7-9, likely tied to tariff-driven macro volatility, then collapsed as the broader market stabilised. The week-on-week move nudged back up 4.5%, but that looks like noise against the larger trend. Borrow availability remains loose — cost to borrow is 0.48%, near its cheapest level in six weeks after peaking at 1.60% in early April. The lending market is not under pressure.
Options tell a slightly different story. The put/call ratio jumped to 0.033, more than two standard deviations above its 20-day average of 0.018. That sounds alarming, but the absolute level is still extremely low — this is a lightly traded options market. The Z-score of 2.3 is elevated, but it reflects a very small move from near-zero put activity to still near-zero put activity. It's a technical flag worth noting, not a sign of genuine defensive positioning.
The Street is broadly aligned to the upside. Multiple analysts raised targets ahead of the print: Truist lifted its target to $36 on April 13, maintaining its Buy. RBC raised to $41 in early March with an Outperform. Wells Fargo nudged to $38 in January. The consensus mean price target of $37.83 implies roughly 20% upside from Tuesday's close, and analyst sentiment has been uniformly constructive over the past six months — every recent action was a raise or an initiation with a positive rating. The PE sits at 22.3x, with EV/EBITDA around 16.2x, multiples that have expanded modestly over the past month as the stock has trended higher. EPS momentum scores in the 63rd percentile on a 30-day basis and 65th on a 90-day view — steady rather than spectacular.
Institutional ownership confirms the accumulation trend. Wasatch Advisors added more than 835,000 shares as of March 31, a notable position build for a firm that now holds about 4% of the company. FMR (Fidelity) added nearly 193,000 shares by end of April. BlackRock added roughly 52,000 shares over the same period. The top 15 holders collectively represent well over 60% of shares outstanding, meaning a relatively thin float is being distributed among a concentrated group of active and passive buyers.
The Q1 call runs May 7. The earnings history shows the stock jumped 10.9% the day after the February 2026 print and held most of that move over five days. The question now is whether the Q1 beat is good enough to extend a run that has already priced in a fair amount of good news — or whether the Street's 20% implied upside to target gives the name room to run further.
See the live data behind this article on ORTEX.
Open PNTG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
